Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Other Accumulated Expenses (2018 - 2019)

Neurogene (NGNE) has disclosed Other Accumulated Expenses for 2 consecutive years, with $339000.0 as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Other Accumulated Expenses rose 41.25% year-over-year to $339000.0, compared with a TTM value of $339000.0 through Dec 2019, up 41.25%, and an annual FY2019 reading of $339000.0, up 41.25% over the prior year.
  • Other Accumulated Expenses was $339000.0 for Q4 2019 at Neurogene, up from $240000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $339000.0 in Q4 2019 and bottomed at $240000.0 in Q4 2018.